Sanofi expects 2023 business EPS to grow low single digits at CER, barring unforeseen major adverse events. Applying average January 2023 exchange rates, the currency impact on 2023 business EPS is estimated between -3.5% to -4.5%.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on SNY:
- Sanofi (NASDAQ:SNY) Stock Down on Mixed Q4 Results
- Sanofi price target raised to EUR 100 from EUR 91 at Berenberg
- Sanofi plans to lay off staff at vaccine factories in India, Reuters says
- Regeneron, Sanofi announce EC expansion of Dupixent marketing authorization
- Regeneron, Sanofi announce CHMP opinion recommending EU approval for Dupixent